Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy
B. Cipolla, E. Mandron, Jean Lefort, et al.
Cancer Prevention Research (2015) Vol. 8, Iss. 8, pp. 712-719
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Combination therapy in combating cancer
Reza Bayat Mokhtari, Tina S. Homayouni, Narges Baluch, et al.
Oncotarget (2017) Vol. 8, Iss. 23, pp. 38022-38043
Open Access | Times Cited: 2027
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Antonio Cuadrado, Ana I. Rojo, Geoffrey Wells, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 4, pp. 295-317
Open Access | Times Cited: 1083
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
Amit Choudhari, Pallavi Mandave, Manasi Deshpande, et al.
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 830
Broccoli or Sulforaphane: Is It the Source or Dose That Matters?
Yoko Yagishita, Jed W. Fahey, Albena T. Dinkova‐Kostova, et al.
Molecules (2019) Vol. 24, Iss. 19, pp. 3593-3593
Open Access | Times Cited: 269
Current evidence on the effect of dietary polyphenols intake on chronic diseases
Chiara Costa, Aristidis Tsatsakis, Charalampos Mamoulakis, et al.
Food and Chemical Toxicology (2017) Vol. 110, pp. 286-299
Closed Access | Times Cited: 237
KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
Albena T. Dinkova‐Kostova, Jed W. Fahey, Rumen V. Kostov, et al.
Trends in Food Science & Technology (2017) Vol. 69, pp. 257-269
Open Access | Times Cited: 234
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment
Paula García-Oliveira, Paz Otero, Antía G. Pereira, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 157-157
Open Access | Times Cited: 210
Retracted: Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy
Alberto Pauletti, Ã Gaetano Terrone, Tawfeeq Shekh‐Ahmad, et al.
Brain (2017) Vol. 140, Iss. 7, pp. 1885-1899
Open Access | Times Cited: 206
Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy
Alberto Pauletti, Gaetano Terrone, Tawfeeq Shekh‐Ahmad, et al.
Brain (2019) Vol. 142, Iss. 7, pp. e39-e39
Open Access | Times Cited: 191
Sulforaphane: Its “Coming of Age” as a Clinically Relevant Nutraceutical in the Prevention and Treatment of Chronic Disease
Christine A. Houghton
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-27
Open Access | Times Cited: 148
Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential
Anna Kaiser, Mojdeh Baniasadi, Derrek Giansiracusa, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4796-4796
Open Access | Times Cited: 112
Isothiocyanates: Translating the Power of Plants to People
Dushani L. Palliyaguru, Jian‐Min Yuan, Thomas W. Kensler, et al.
Molecular Nutrition & Food Research (2018) Vol. 62, Iss. 18
Open Access | Times Cited: 157
Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase
Jed W. Fahey, W. David Holtzclaw, Scott L. Wehage, et al.
PLoS ONE (2015) Vol. 10, Iss. 11, pp. e0140963-e0140963
Open Access | Times Cited: 140
The Integrative Role of Sulforaphane in Preventing Inflammation, Oxidative Stress and Fatigue: A Review of a Potential Protective Phytochemical
Ruheea Taskin Ruhee, Katsuhiko Suzuki
Antioxidants (2020) Vol. 9, Iss. 6, pp. 521-521
Open Access | Times Cited: 129
Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane
Julie E. Bauman, Yan Zang, Malabika Sen, et al.
Cancer Prevention Research (2016) Vol. 9, Iss. 7, pp. 547-557
Open Access | Times Cited: 96
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
Srinivas Patnaik, S Anupriya
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 95
Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets
Fabrizio Fontana, M. Raimondi, Monica Marzagalli, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 460-460
Open Access | Times Cited: 86
Current Landscape of NRF2 Biomarkers in Clinical Trials
Yoko Yagishita, Tonibelle Gatbonton-Schwager, Melissa L. McCallum, et al.
Antioxidants (2020) Vol. 9, Iss. 8, pp. 716-716
Open Access | Times Cited: 80
Anticancer properties of sulforaphane: current insights at the molecular level
Muhammad Asif Ali, Noohela Khan, Nabeeha Kaleem, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 31
Exploring the anti‐inflammatory activity of sulforaphane
Katie Treasure, James Harris, Gary Williamson
Immunology and Cell Biology (2023) Vol. 101, Iss. 9, pp. 805-828
Open Access | Times Cited: 24
Bioactive sulforaphane from cruciferous vegetables: advances in biosynthesis, metabolism, bioavailability, delivery, health benefits, and applications
Yanli Zhang, Wenyuan Zhang, Yaqi Zhao, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-21
Closed Access | Times Cited: 9
The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
Jed W. Fahey, Mirran Raphaely
Applied Sciences (2025) Vol. 15, Iss. 2, pp. 522-522
Open Access | Times Cited: 1
Isothiocyanates from Brassica Vegetables—Effects of Processing, Cooking, Mastication, and Digestion
Teresa Oliviero, Ruud Verkerk, Matthijs Dekker
Molecular Nutrition & Food Research (2018) Vol. 62, Iss. 18
Open Access | Times Cited: 81
Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity
David Olagnier, Rassin Lababidi, Samar Bel Hadj, et al.
Molecular Therapy (2017) Vol. 25, Iss. 8, pp. 1900-1916
Open Access | Times Cited: 77
Epigenetic modulators as therapeutic targets in prostate cancer
Inês Graça, Eva Pereira-Silva, Rui Henrique, et al.
Clinical Epigenetics (2016) Vol. 8, Iss. 1
Open Access | Times Cited: 74
Page 1 - Next Page

Scroll to top